143 related articles for article (PubMed ID: 33652465)
1. Neuropsychological Assessment Should Always be Considered in Myotonic Dystrophy Type 2.
Theodosiou T; Christidi F; Xirou S; Bede P; Karavasilis E; Papadopoulos C; Kourtesis P; Pantoleon V; Kararizou E; Papadimas G; Zalonis I
Cogn Behav Neurol; 2021 Mar; 34(1):1-10. PubMed ID: 33652465
[TBL] [Abstract][Full Text] [Related]
2. Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2.
Peric S; Mandic-Stojmenovic G; Stefanova E; Savic-Pavicevic D; Pesovic J; Ilic V; Dobricic V; Basta I; Lavrnic D; Rakocevic-Stojanovic V
J Neurol; 2015 Jan; 262(1):142-8. PubMed ID: 25346064
[TBL] [Abstract][Full Text] [Related]
3. Brain positron emission tomography in patients with myotonic dystrophy type 1 and type 2.
Peric S; Brajkovic L; Belanovic B; Ilic V; Salak-Djokic B; Basta I; Rakocevic Stojanovic V
J Neurol Sci; 2017 Jul; 378():187-192. PubMed ID: 28566162
[TBL] [Abstract][Full Text] [Related]
4. Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2.
Romeo V; Pegoraro E; Ferrati C; Squarzanti F; Sorarù G; Palmieri A; Zucchetta P; Antunovic L; Bonifazi E; Novelli G; Trevisan CP; Ermani M; Manara R; Angelini C
J Neurol; 2010 Aug; 257(8):1246-55. PubMed ID: 20221771
[TBL] [Abstract][Full Text] [Related]
5. Clusters of cognitive impairment among different phenotypes of myotonic dystrophy type 1 and type 2.
Peric S; Rakocevic Stojanovic V; Mandic Stojmenovic G; Ilic V; Kovacevic M; Parojcic A; Pesovic J; Mijajlovic M; Savic-Pavicevic D; Meola G
Neurol Sci; 2017 Mar; 38(3):415-423. PubMed ID: 27896491
[TBL] [Abstract][Full Text] [Related]
6. Cognitive assessment in patients with myotonic dystrophy type 2.
Peric S; Gunjic I; Delic N; Stojiljkovic Tamas O; Salak-Djokic B; Pesovic J; Petrovic Djordjevic I; Ivanovic V; Savic-Pavicevic D; Meola G; Rakocevic-Stojanovic V
Neuromuscul Disord; 2022 Sep; 32(9):743-748. PubMed ID: 35879188
[TBL] [Abstract][Full Text] [Related]
7. Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.
Schneider-Gold C; Bellenberg B; Prehn C; Krogias C; Schneider R; Klein J; Gold R; Lukas C
PLoS One; 2015; 10(6):e0130352. PubMed ID: 26114298
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment in adult myotonic dystrophies: a longitudinal study.
Sansone V; Gandossini S; Cotelli M; Calabria M; Zanetti O; Meola G
Neurol Sci; 2007 Mar; 28(1):9-15. PubMed ID: 17385090
[TBL] [Abstract][Full Text] [Related]
9. Executive Dysfunction, Social Cognition Impairment, and Gray Matter Pathology in Myotonic Dystrophy Type 2: A Pilot Study.
Theodosiou T; Christidi F; Xirou S; Karavasilis E; Bede P; Papadopoulos C; Argyropoulos GD; Kourtesis P; Pantolewn V; Ferentinos P; Kararizou E; Velonakis G; Zalonis I; Papadimas G
Cogn Behav Neurol; 2022 Sep; 35(3):204-211. PubMed ID: 35867610
[TBL] [Abstract][Full Text] [Related]
10. A new window on neurocognitive dysfunction in the childhood form of myotonic dystrophy type 1 (DM1).
Angeard N; Jacquette A; Gargiulo M; Radvanyi H; Moutier S; Eymard B; Héron D
Neuromuscul Disord; 2011 Jul; 21(7):468-76. PubMed ID: 21592796
[TBL] [Abstract][Full Text] [Related]
11. Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study.
Gliem C; Minnerop M; Roeske S; Gärtner H; Schoene-Bake JC; Adler S; Witt JA; Hoffstaedter F; Schneider-Gold C; Betz RC; Helmstaedter C; Tittgemeyer M; Amunts K; Klockgether T; Weber B; Kornblum C
PLoS One; 2019; 14(3):e0213381. PubMed ID: 30845252
[TBL] [Abstract][Full Text] [Related]
12. Cognition in myotonic dystrophy type 1: a 5-year follow-up study.
Winblad S; Samuelsson L; Lindberg C; Meola G
Eur J Neurol; 2016 Sep; 23(9):1471-6. PubMed ID: 27323306
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2.
Weber YG; Roebling R; Kassubek J; Hoffmann S; Rosenbohm A; Wolf M; Steinbach P; Jurkat-Rott K; Walter H; Reske SN; Lehmann-Horn F; Mottaghy FM; Lerche H
Neurology; 2010 Apr; 74(14):1108-17. PubMed ID: 20220122
[TBL] [Abstract][Full Text] [Related]
14. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
[TBL] [Abstract][Full Text] [Related]
15. Comparison of temporal and stride characteristics in myotonic dystrophies type 1 and 2 during dual-task walking.
Radovanović S; Perić S; Savić-Pavićević D; Dobričić V; Pešović J; Kostić V; Rakočević-Stojanović V
Gait Posture; 2016 Feb; 44():194-9. PubMed ID: 27004657
[TBL] [Abstract][Full Text] [Related]
16. Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1.
Labayru G; Diez I; Sepulcre J; Fernández E; Zulaica M; Cortés JM; López de Munain A; Sistiaga A
Neuroimage Clin; 2019; 24():102078. PubMed ID: 31795042
[TBL] [Abstract][Full Text] [Related]
17. Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2).
Gaul C; Schmidt T; Windisch G; Wieser T; Müller T; Vielhaber S; Zierz S; Leplow B
Neurology; 2006 Jul; 67(2):350-2. PubMed ID: 16864839
[TBL] [Abstract][Full Text] [Related]
18. Cerebral involvement and related aspects in myotonic dystrophy type 2.
Peric S; Rakocevic-Stojanovic V; Meola G
Neuromuscul Disord; 2021 Aug; 31(8):681-694. PubMed ID: 34244019
[TBL] [Abstract][Full Text] [Related]
19. Brain Involvement in Myotonic Dystrophy Type 1: A Morphometric and Diffusion Tensor Imaging Study with Neuropsychological Correlation.
Cabada T; Iridoy M; Jericó I; Lecumberri P; Seijas R; Gargallo A; Gomez M
Arch Clin Neuropsychol; 2017 Jun; 32(4):401-412. PubMed ID: 28164212
[TBL] [Abstract][Full Text] [Related]
20. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
